Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/medecine/hormone-receptors-in-breast-cancer-cancer-treatment-et-research-vol-47/fuqua/descriptif_1269940
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=1269940

Hormone Receptors in Breast Cancer, . 2nd Printing. 2008 Cancer Treatment and Research Series, Vol. 147

Langue : Anglais

Coordonnateur : Fuqua Suzanne A. W.

Couverture de l’ouvrage Hormone Receptors in Breast Cancer

Hormone Receptors in Breast Cancer provides an up-to-date resource of the role of hormone receptors in breast cancer written in depth for both the basic molecular academic researcher and translational scientist. Advances in basic science of molecular endocrinology have undoubtedly been translated into clinical practice, and clinicians caring for this disease need to be knowledgeable about these developments. The molecular basis of hormone action has been elucidated, and the relative significance of the different estrogen and progesterone receptor isoforms has been explored. This explosion of information has lead to exciting new areas of gene specific targeting of the disease, and breast cancer prevention. Paradigm shifts in treatment options and sequencing have recently occurred in breast cancer management, necessitating close cooperation and communication between translational scientists and physicians. This book is focused on providing this communication.

Hormone Action and Clinical Significance of the Estrogen Receptor #x03B1;.- Role of ER#x03B2; in Clinical Breast Cancer.- Hormone Action and Breast Cancer.- Estrogen Receptors in Breast Tumors of African American Patients.- BRCA1 Cross-Talk with Hormone Receptors.- Metastasis of Hormone Receptor Positive Breast Cancer.- Endocrine Therapy with Selective Estrogen Receptor Modulators (SERMs) and Aromatase Inhibitors in the Prevention and Adjuvant Therapy Settings.- Biomarkers in Neoadjuvant Trials.- Hormone Resistance.- Strategies of Hormonal Prevention.- Estrogen Receptor Phenotypes Defined by Gene Expression Profiling.
The book will be of value as a significant resource for the practicing clinician keeping abreast of the most current targeted and combination hormone therapies for breast cancer managment and prevention strategies.

Date de parution :

Ouvrage de 281 p.

15.5x23.5 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

116,04 €

Ajouter au panier

Date de parution :

Ouvrage de 281 p.

15.5x23.5 cm

Sous réserve de disponibilité chez l'éditeur.

158,24 €

Ajouter au panier